
Abivax Stock Soars on Acquisition Rumors from Eli Lilly
San Diego, December 11, 2025 Abivax, a French biotech firm, experienced a stock surge of over 20% fueled by speculation of a potential acquisition by the
Explore the latest news and developments in the San Diego, CA pharmaceutical industry on our dedicated category page. Stay informed about groundbreaking research, innovations in drug development, and key partnerships among biotech companies and pharmaceutical firms. Discover stories highlighting local startups that are making waves in the life sciences sector, as well as updates on clinical trials and regulatory approvals. Our curated content focuses on advancements in pharmaceuticals, biotechnology trends, and the impact of local research institutions on the global healthcare landscape.
In addition to news articles, this category page offers insights into events, conferences, and forums taking place in San Diego that focus on the pharmaceutical sector. Learn about prominent figures and thought leaders in the industry who are shaping the future of medicine and healthcare. Whether you are a healthcare professional, researcher, or simply interested in the pharmaceutical innovations emerging from San Diego, this page serves as your go-to resource for comprehensive coverage and analysis. Keep up with the evolving landscape of pharmaceuticals in one of the country’s leading biotech hubs.

San Diego, December 11, 2025 Abivax, a French biotech firm, experienced a stock surge of over 20% fueled by speculation of a potential acquisition by the

San Diego, December 5, 2025 Capricor Therapeutics’ stock surged over 340% after positive results from its Phase 3 HOPE-3 trial for Deramiocel, a treatment for Duchenne

San Diego, November 25, 2025 San Diego emphasizes the importance of marine ecosystems for drug discovery, as marine biodiversity is crucial for developing new pharmaceuticals. Challenges

News Summary Novartis has announced plans to acquire San Diego-based Avidity Biosciences for approximately $12 billion in an all-cash deal. This strategic acquisition aims to

News Summary San Diego is set to welcome a $1.1 billion research hub from Novartis, creating nearly 1,000 direct jobs and 4,000 additional jobs nationwide.